Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort

Burgess NG, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, Mahajan H, McLeod D, Bourke MJ

(2017), Gastroenterology, 153(3), 732-42.e1

DOI: 10.1053/j.gastro.2017.05.047

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people? Authors' reply

Ward MG, Irving PM

(2017), Aliment Pharmacol Ther, 46(4), 465

DOI: 10.1111/apt.14209

How to perform gastrointestinal ultrasound: anatomy and normal findings

Atkinson NSS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, Nuernberg D, Schreiber-Dietrich D, Dietrich CF

(2017), World J Gastroenterol, 23(38), 6931-41

DOI: 10.3748/wjg.v23.i38.6931

Transperineal Ultrasound for Perianal Fistulas and Abscesses - A Systematic Review and Meta-Analysis

Maconi G, Greco MT, Asthana AK

(2017), Ultraschall Med, 38(3), 265-72

DOI: 10.1055/s-0043-103954

When the low FODMAP diet does not work

Halmos EP

(2017), J Gastroenterol Hepatol, 32 (Suppl 1), 69-72

DOI: 10.1111/jgh.13701

Easing Concerns About the Low FODMAP Diet in Patients With Irritable Bowel Syndrome

Gibson PR, Burgell RE

(2017), Gastroenterology, 153(4), 886-7

DOI: 10.1053/j.gastro.2017.08.055

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study

Majeed A, ?gren A, Holmstràm M, Bruzelius M, Chaireti R, Odeberg J, Hempel EL, Magnusson M, Frisk T, Schulman S

(2017), Blood, 130(15), 1706-12

DOI: 10.1182/blood-2017-05-782060

The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus

Bye WA, Sparrow MP, Connor SJ, Andrews JM, Ellard K, Ng W, Hume G, Antoniades S, Walsh AJ

(2017), Intern Med J, 47(11), 1263-9

DOI: 10.1111/imj.13488

Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method

Chen GB, Lee SH, Montgomery GW, Wray NR, Visscher PM, Gearry RB, Lawrance IC, Andrews JM, Bampton P, Mahy G, Bell S, Walsh A, Connor S, Sparrow M, Bowdler LM, Simms LA, Krishnaprasad K; International IBD Genetics Consortium, Radford-Smith GL, Moser G

(2017), BMC Med Genet, 18, 94

DOI: 10.1186/s12881-017-0451-2

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Vermeire S, Sandborn WJ, Danese S, H»buterne X, Salzberg BA, Klopocka M, Tarabar D, Vanasek T, GreguŠ M, Hellstern PA, Kim JS, Sparrow MP, Gorelick KJ, Hinz M, Ahmad A, Pradhan V, Hassan-Zahraee M, Clare R, Cataldi F, Reinisch W

(2017), Lancet, 390(10090), 135-44

DOI: 10.1016/S0140-6736(17)30930-3

Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease

Julsgaard M, Hvas CL, Gearry RB, Vestergaard T, Fallingborg J, Svenningsen L, Kjeldsen J, Sparrow MP, Wildt S, Kelsen J, Bell SJ

(2017), Inflamm Bowel Dis, 23(7), 1240-6

DOI: 10.1097/MIB.0000000000001136

Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target

Sparrow MP

(2017), Expert Opin Biol Ther, 17(5), 613-21

DOI: 10.1080/14712598.2017.1309390

Editorial: variability in adalimumab trough and peak serum concentrations - authors' reply

Ward MG, Gibson PR, Sparrow MP

(2017), Aliment Pharmacol Ther, 45(11), 1476-7

DOI: 10.1111/apt.14091

Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline

Su HY, Ward MG, Sparrow MP

(2017), Transl Gastroenterol Hepatol, 2, 113

DOI: 10.21037/tgh.2017.12.05

Is there a role for thioguanine therapy in IBD in 2017 and beyond?

Taylor KM, Ward MG, Blaker PA, Sparrow MP

(2017), Expert Rev Gastroenterol Hepatol, 11(5), 473-86

DOI: 10.1080/17474124.2017.1294062

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Goel G, King T, Daveson AJ, Andrews JM, Krishnarajah J, Krause R, Brown GJE, Fogel R, Barish CF, Epstein R, Kinney TP, Miner PB Jr, Tye-Din JA, Girardin A, Taavela J, Popp A, Sidney J, Mâki M, Goldstein KE, Griffin PH, Wang S, Dzuris JL, Williams LJ, Sette A, Xavier RJ, Sollid LM, Jabri B, Anderson RP

(2017), Lancet Gastroenterol Hepatol, 2(7), 479-93

DOI: 10.1016/S2468-1253(17)30110-3

Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool

Tate DJ, Desomer L, Klein A, Brown G, Hourigan LF, Lee EY, Moss A, Ormonde D, Raftopoulos S, Singh R, Williams SJ, Zanati S, Byth K, Bourke MJ

(2017), Gastrointest Endosc, 85(3), 647-56.e6

DOI: 10.1016/j.gie.2016.11.027

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse

Aggarwal V, Day AS, Connor S, Leach ST, Brown G, Singh R, Friedman A, Zekry A, Craig PI

(2017), Gastrointest Endosc, 86(6), 1070-8

DOI: 10.1016/j.gie.2017.09.011

Hepatobiliary and pancreatic: hepatic and mesenteric aneurysms with biloma formation

Ling QA, Yo J, Gerstenmaier JF, Kemp W

(2017), J Gastroenterol Hepatol, 32(6), 1134

DOI: 10.1111/jgh.13765

Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review

Batchelor R, Gilmartin JF, Kemp W, Hopper I, Liew D

(2017), J Gastroenterol Hepatol, 32(8), 1426-35

DOI: 10.1111/jgh.13750

7 8 9 10 11